炎症癌相关成纤维细胞介导结直肠癌细胞耐药的机制研究

doi:10.19401/j.cnki.1007-3639.2023.12.001

中国癌症杂志 ›› 2023, Vol. 33 ›› Issue (12): 1065-1072.doi: 10.19401/j.cnki.1007-3639.2023.12.001

炎症癌相关成纤维细胞介导结直肠癌细胞耐药的机制研究

蔡家洛¹^,²(), 朱锐秋¹^,³, 李森¹, 曹亦军¹, 黄坊⁴()

1.上海中医药大学附属普陀医院普外科，上海 200062
2.华东理工大学药学院，上海 200237
3.安徽医科大学上海普陀中心临床学院，上海 200062
4.上海中医药大学附属普陀医院病理科，上海 200062

收稿日期:2022-11-17 修回日期:2023-10-20 出版日期:2023-12-30 发布日期:2023-12-28
通信作者: 黄坊（ORCID: 0009-0005-2372-4639），硕士，主治医师。
作者简介:蔡家洛（ORCID: 0009-0001-8102-026X），硕士。
基金资助:
上海市普陀区中心医院雏鹰计划(2022-RCCY-08)

Mechanism of inflammatory cancer-associated fibroblast-mediated drug resistance in colorectal cancer cells

CAI Jialuo¹^,²(), ZHU Ruiqiu¹^,³, LI Sen¹, CAO Yijun¹, HUANG Fang⁴()

1. Department of General Surgery, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China
2. School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China
3. Shanghai Putuo Central School of Clinical Medicine, Anhui Medical University, Shanghai 200062, China
4. Department of Pathology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China

Received:2022-11-17 Revised:2023-10-20 Published:2023-12-30 Online:2023-12-28
Contact: HUANG Fang.

摘要/Abstract

摘要：

背景与目的： 结直肠癌（colorectal cancer，CRC）是常见的消化系统恶性肿瘤之一，但是其产生肿瘤耐药的机制仍不清楚。肿瘤微环境（tumor microenvironment，TME），尤其是其中的癌相关成纤维细胞（cancer-associated fibroblast，CAF），在肿瘤的发生、发展及耐药过程中都发挥重要作用。本研究旨在探讨炎症CAF（inflammatory CAF，iCAF）对CRC细胞耐药的影响及可能的分子机制。方法： 提取来自上海中医药大学附属普陀医院（2022年8月——2022年9月）诊治的CRC患者并经手术切除的CRC组织以获得原代CAF[获得上海中医药大学附属普陀医院伦理委员会批准，编号：PTEC-A-2023-5（S）-1]，按照CAF的表面标志物血小板源性生长因子受体α（platelet derived growth factor receptor alpha，PDGFRA）对原代细胞进行分选，筛选出iCAF。使用不添加血清的培养基分别对人结肠成纤维细胞（human intestinal fibroblast，HIF）和iCAF进行培养以获取HIF条件培养基（HIF-conditioned medium，HIF-CM）和iCAF条件培养基（iCAF-conditioned medium，iCAF-CM）。根据处理方式将结肠癌细胞分为对照组（不处理）、实验组1（加入HIF-CM）和实验组2（加入iCAF-CM）。观察经HIF或iCAF刺激后CRC细胞的存活率变化、凋亡率、蛋白水平、mRNA水平变化及对Wnt/β-catenin信号转导通路的影响。结果： 经iCAF刺激后，CRC细胞的半数抑制浓度（half inhibition concentration，IC₅₀）较对照组和HIF-CM组升高（P<0.05）。与对照组和HIF-CM组相比，iCAF-CM组肿瘤细胞的凋亡率明显下降，凋亡蛋白caspase-3的表达量下降，抗凋亡蛋白Bcl-2、Bcl-xL和survivin表达量均上升（P<0.05）。iCAF-CM组Wnt/β-catenin信号转导通路被激活。结论： iCAF可以介导CRC细胞产生耐药，其机制与激活Wnt/β-catenin信号转导通路有关。

Abstract:

Background and purpose: Colorectal cancer (CRC) is one of the common malignancies, but the mechanism by which it develops resistance to drug remains unclear. The tumor microenvironment (TME), especially cancer-associated fibroblast (CAF), plays an important role in the occurrence, development and drug resistance of tumors. This study aimed to investigate the effect of inflammatory cancer-associated fibroblasts (iCAF) on drug resistance in CRC cells and its possible mechanism. Methods: The primary CAFs were collected from CRC patients underwent surgery in Putuo Hospital, Shanghai University of Traditional Chinese Medicine from Aug. 2022 to Sep. 2022, and the primary cells were sorted according to the surface marker of CAF[approved by the Ethics Committee of Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine: PTEC-A-2023-5(S)-1], platelet derived growth factor receptor alpha (PDGFRA), to screen iCAF. Human intestinal fibroblast (HIF) and iCAF cells were cultured using serum-free medium to obtain conditioned medium. According to the treatment method, colon cancer cells were divided into control group (no treatment), experimental group 1(treated with HIF-CM) and experimental group 2 (treated with iCAF-CM). We observed the changes in the survival rate and apoptotic rate of CRC cells, the changes in protein and mRNA levels and the effect on the Wnt/β-catenin signaling pathway after stimulation with HIF-CM or iCAF-CM. Results: After iCAFs stimulation, the half inhibition concentration (IC₅₀) of CRC cells was higher compared with the control group and HIF-CM group (P<0.05). Compared with the control group and HIF-CM group, the apoptotic rate of tumor cells in iCAF-CM group decreased significantly, the expression of caspase-3 was decreased, and the expressions of Bcl-2, Bcl-xL and survivin were increased (P<0.05). The Wnt/β-catenin signaling pathway was activated in the iCAF-CM group. Conclusion: iCAFs can mediate drug resistance in CRC cells, and the mechanism is related to the activation of Wnt/β-catenin signaling pathway.

Key words: Colorectal cancer, Inflammatory cancer-associated fibroblasts, Drug resistance, Wnt/β-catenin signaling pathway

中图分类号:

蔡家洛, 朱锐秋, 李森, 曹亦军, 黄坊. 炎症癌相关成纤维细胞介导结直肠癌细胞耐药的机制研究[J]. 中国癌症杂志, 2023, 33(12): 1065-1072.

CAI Jialuo, ZHU Ruiqiu, LI Sen, CAO Yijun, HUANG Fang. Mechanism of inflammatory cancer-associated fibroblast-mediated drug resistance in colorectal cancer cells[J]. China Oncology, 2023, 33(12): 1065-1072.

图/表 6

图1

图2

图3

图4

图5

图6

参考文献 15

[1]	周昌明, 王泽洲, 郑莹. 2023年美国癌症数据解读及对中国癌症防治的启示[J]. 中国癌症杂志, 2023, 33(2): 117-125. doi: 10.19401/j.cnki.1007-3639.2023.02.004
	ZHOU C M, WANG Z Z, ZHENG Y. Interpretation of US cancer statistics 2023 and its implications for cancer prevention and treatment in China[J]. China Oncol, 2023, 33(2): 117-125.
[2]	NIKOLAOU M, PAVLOPOULOU A, GEORGAKILAS A G, et al. The challenge of drug resistance in cancer treatment: a current overview[J]. Clin Exp Metastasis, 2018, 35(4): 309-318. doi: 10.1007/s10585-018-9903-0
[3]	SUN Y. Tumor microenvironment and cancer therapy resistance[J]. Cancer Lett, 2016, 380(1): 205-215. doi: 10.1016/j.canlet.2015.07.044 pmid: 26272180
[4]	ELYADA E, BOLISETTY M, LAISE P, et al. Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts[J]. Cancer Discov, 2019, 9(8): 1102-1123. doi: 10.1158/2159-8290.CD-19-0094 pmid: 31197017
[5]	BU L K, BABA H, YASUDA T, et al. Functional diversity of cancer-associated fibroblasts in modulating drug resistance[J]. Cancer Sci, 2020, 111(10): 3468-3477. doi: 10.1111/cas.v111.10
[6]	YOSHIDA G J. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways[J]. J Exp Clin Cancer Res, 2020, 39(1): 112. doi: 10.1186/s13046-020-01611-0 pmid: 32546182
[7]	CHEN Z H, ZHOU L J, LIU L L, et al. Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma[J]. Nat Commun, 2020, 11(1): 5077. doi: 10.1038/s41467-020-18916-5 pmid: 33033240
[8]	SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. doi: 10.3322/caac.v71.3
[9]	KADEL D, ZHANG Y, SUN H R, et al. Current perspectives of cancer-associated fibroblast in therapeutic resistance: potential mechanism and future strategy[J]. Cell Biol Toxicol, 2019, 35(5): 407-421. doi: 10.1007/s10565-019-09461-z pmid: 30680600
[10]	SAHAI E, ASTSATUROV I, CUKIERMAN E, et al. A framework for advancing our understanding of cancer-associated fibroblasts[J]. Nat Rev Cancer, 2020, 20(3): 174-186. doi: 10.1038/s41568-019-0238-1 pmid: 31980749
[11]	李学勤, 徐克. 肿瘤相关成纤维细胞促进肿瘤侵袭转移的作用机制[J]. 中国生物化学与分子生物学报, 2019, 35(4): 386-392. doi: 10.13865/j.cnki.cjbmb.2019.04.06
	LI X Q, XU K. Mechanism of cancer-associated fibroblasts promoting tumor metastasis and invasion[J]. Chin J Biochem Mol Biol, 2019, 35(4): 386-392.
[12]	HU J L, WANG W, LAN X L, et al. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer[J]. Mol Cancer, 2019, 18(1): 91. doi: 10.1186/s12943-019-1019-x pmid: 31064356
[13]	ZHANG F, CUI J Y, GAO H F, et al. Cancer-associated fibroblasts induce epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer via CXCL12/CXCR4 axis[J]. Future Oncol, 2020, 16(32): 2619-2633. doi: 10.2217/fon-2020-0095
[14]	JUNG Y S, PARK J I. Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex[J]. Exp Mol Med, 2020, 52(2): 183-191. doi: 10.1038/s12276-020-0380-6
[15]	FERRARI N, RANFTL R, CHICHEROVA I, et al. Dickkopf-3 links HSF1 and YAP/TAZ signalling to control aggressive behaviours in cancer-associated fibroblasts[J]. Nat Commun, 2019, 10(1): 130. doi: 10.1038/s41467-018-07987-0 pmid: 30631061

炎症癌相关成纤维细胞介导结直肠癌细胞耐药的机制研究

Mechanism of inflammatory cancer-associated fibroblast-mediated drug resistance in colorectal cancer cells

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

图/表 6

参考文献 15

相关文章 15

编辑推荐

Metrics

本文评价

[1]	周聪, 何丽娜, 成小姣, 黄廷磊, 涂水平. RSPO3抑制体内结直肠癌移植瘤生长和增加NK细胞浸润的作用研究[J]. 中国癌症杂志, 2023, 33(7): 664-672.
[2]	冶俊玲, 郑小影, 郭新建, 陈瑞慧, 杨柳, 苟笑丹, 蒋汉梅. LncRNA SNHG5/miR-26a-5p/MTDH信号轴促进结直肠癌转移的机制研究[J]. 中国癌症杂志, 2023, 33(7): 673-685.
[3]	胡可舒, 刘文凤, 张锋, 权冰, 殷欣. 长链非编码RNA LINC00601调控肝细胞癌奥沙利铂耐药的分子机制研究[J]. 中国癌症杂志, 2023, 33(1): 25-35.
[4]	何丽媛, 王玉栋. ALK激酶域耐药突变的研究进展及未来应对策略[J]. 中国癌症杂志, 2022, 32(8): 736-746.
[5]	陈玺, 曾晓颖, 陈佳艳, 刘菲, 唐曦. 错配修复蛋白联合血清肿瘤标志物与Ki-67增殖指数对结直肠癌预后的临床价值[J]. 中国癌症杂志, 2022, 32(3): 243-250.
[6]	王乾, 张静, 郁成礼, 包龙龙, 蔡旭, 蒋文华, 黄丹, 盛伟琪, 朱晓丽, 周晓燕, 柏乾明. 全自动Idylla^TM系统在中国结直肠癌微卫星不稳定性检测中的可行性研究[J]. 中国癌症杂志, 2022, 32(11): 1084-1090.
[7]	贾真真, 何双, 李扬扬, 温菲菲, 许晓阳, 郭宁杰, 吴淑华. 结直肠癌中DPD与LC3、P62表达的相关性及其临床意义[J]. 中国癌症杂志, 2022, 32(1): 24-33.
[8]	马祎菲, 梁新军, 魏少忠 . 炎症与免疫指标在可切除性结直肠癌中的预后价值[J]. 中国癌症杂志, 2021, 31(9): 845-851.
[9]	张迎强, 林岩松 . ⁹⁰Y微球选择性内放射治疗在结直肠癌肝转移中的应用及研究进展[J]. 中国癌症杂志, 2021, 31(8): 762-768.
[10]	郑培明, 李俊蒙, 张　鹏, 高　岚 . 巨噬细胞外泌体源miR-223促进胃癌细胞对奥沙利铂的耐药研究[J]. 中国癌症杂志, 2021, 31(5): 368-378.
[11]	花　晴, 申雪芳, 许平波. KLK8通过调节EGF对结直肠癌细胞凋亡的影响及其机制[J]. 中国癌症杂志, 2021, 31(5): 383-389.
[12]	马维东, 王彤彤, 朱启航, 杨海鸥, 林　丹. 外泌体中circ_0044366调控肿瘤相关成纤维细胞MMP2的表达促进结直肠癌转移的机制研究[J]. 中国癌症杂志, 2021, 31(5): 397-407.
[13]	李瑞晓, 唐启胜, 马善金, 张　波, 李雪莲, 张志明 . NDRG2通过抑制Bcl-2表达增加膀胱癌细胞对顺铂的敏感性[J]. 中国癌症杂志, 2021, 31(4): 263-267.
[14]	陈馨宁, 黄　斐, 沈敏娜, 杨轶慧, 王蓓丽, 郭　玮 . 转移性结直肠癌患者ctDNA基因突变检测方法的比较及影响因素分析[J]. 中国癌症杂志, 2021, 31(3): 192-197.
[15]	汪　明, 曹　晖. 晚期胃肠间质瘤药物治疗进展[J]. 中国癌症杂志, 2021, 31(2): 90-99.